Summary

for people ages 18-70 (full criteria)
at La Jolla, California and other locations
study started
estimated completion:

Description

Summary

The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.

Official Title

A Phase 2b, Double-blind, Randomized, Placebo-controlled, Parallel Group, Dose Ranging Study Of Oral Pf-06651600 And Pf-06700841 As Induction And Chronic Therapy In Subjects With Moderate To Severe Ulcerative Colitis

Keywords

Ulcerative Colitis Mayo score Colitis Ulcer Colitis, Ulcerative

Eligibility

You can join if…

Open to people ages 18-70

  • Diagnosis of ulcerative colitis for greater than/equal to 4 months.
  • Moderate to severe active ulcerative colitis
  • Inadequate response to, loss of response to, or intolerance to at least one conventional therapy for UC.

You CAN'T join if...

  • Pregnant or breastfeeding
  • Clinical findings suggestive of Crohn's Disease
  • History of bowel surgery within 6 months

Locations

  • UCSD Investigational Drug Services not yet accepting patients
    La Jolla California 92037 United States
  • UCSD Perlman Medical Offices not yet accepting patients
    La Jolla California 92037 United States
  • UCSD Thorntorn Hospital not yet accepting patients
    La Jolla California 92037 United States
  • UCSD Altman Clinical and Transitional Research Institute not yet accepting patients
    La Jolla California 92093 United States
  • Medical Associates Research Group accepting new patients
    San Diego California 92123 United States
  • Clinical Application Laboratories, INC. accepting new patients
    San Diego California 92103 United States
  • San Diego Endoscopy Center accepting new patients
    San Diego California 92103 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Pfizer
Links
To obtain contact information for a study center near you, click here.
To obtain contact information for a study center near you, click here.
To obtain contact information for a study center near you, click here.
ID
NCT02958865
Phase
Phase 2
Study Type
Interventional
Last Updated
July 23, 2018